Joshua Reed

CIK 1746541 · SVP, Chief Financial Officer · last filed 2026-06-08

Joshua Reed is a SVP, Chief Financial Officer who has filed 20 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for SRRK, was dated Jun 8, 2026. Across all open-market trades the lifetime net is −$145.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.48M

Companies

4

Total Filings

20

Lifetime Open-Market Net

-$145.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SRRK Director 22,571 $44.18 $997.2K -$160.5K 7 2026-06-08
ALKS SVP, Chief Financial Officer $44.28 $0 2 2026-03-04
Omega Therapeutics, Inc. (OMGA) Delisted Chief Financial Officer $0.14 $0 4 2024-02-09
ALDX Chief Financial Officer 274,825 $1.76 $483.7K $15.1K 7 2022-04-01

Recent Filings

20 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-08 SRRK Grant (A) +6,839 $0 EDGAR
2026-03-04 ALKS Grant (A) $0 EDGAR
2025-10-10 ALKS Grant (A) $0 EDGAR
2025-05-30 SRRK Sell (S) −5,400 -$160.5K EDGAR
2025-05-23 SRRK Grant (A) +7,632 $0 EDGAR
2024-07-01 SRRK Grant (A) +13,500 $0 EDGAR
2024-02-09 Omega Therapeutics, Inc. (OMGA) Delisted Grant (A) $0 EDGAR
2023-06-22 SRRK Grant (A) $0 EDGAR
2023-03-02 Omega Therapeutics, Inc. (OMGA) Delisted Grant (A) $0 EDGAR
2022-10-28 Omega Therapeutics, Inc. (OMGA) Delisted Grant (A) $0 EDGAR
Showing 110 of 20
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.